Impax Reports First Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Impax Laboratories (IPXL) Tops Q1 EPS by 4c
May 10, 2016 6:43 AM EDTImpax Laboratories (NASDAQ: IPXL) reported Q1 EPS of $0.43, $0.04 better than the analyst estimate of $0.39. Revenue for the quarter came in at $226 million versus the consensus estimate of $247.2 million.
Impax Laboratories reaffirmed FY2016 guidance.
For earnings history and earnings-related data on Impax Laboratories (IPXL) click here.
... More